Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 314 days ( -1.60 % )
Last Price 1.27€ -9.93 %
High/ Low 1.27€ - 1.27€ -6.30%
Chg 7 Days -5.93 % $1.35 1.27€
Chg 30 Days -1.55 % $1.29 1.27€
Chg 12 mos 9.48 % $1.16 1.27€
Trend - 3 mos 28.48 % Width: 28.85 %
Trend - 12 mos -21.73 % Width: 717.28 %
Pred. range - 3 mos 1.60€ - 2.06€ 25.72 % - 61.99 %
Pred. range - 12 mos 0.232€ - 1.90€ -81.72 % - 49.39 %
Short MA avg 3 mos Buy 2023-04-14 - 3 days
Long MA avg 3 mos Sell 2023-04-17 - 2 days
Short/Long MA avg 3 mos Buy 2023-03-01 - 33 days
Short MA avg 12 mos Sell 2023-04-17 - 2 days
Long MA avg 12 mos Buy 2023-03-06 - 30 days
Short/Long MA avg 12 mos Buy 2023-03-09 - 27 days
Pivot Short Sell 2023-04-17 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD Buy No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About DBV Technologies S.A.

DBV Technologies S.A. DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBVA.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT